The superoxide dismutase mimetic MnTBAP prevents Fas-induced acute liver failure in the mouse

Gastroenterology

Volumn 121, Issue 6, 2001, Pages 1451-1459

  Malassagne, Benot ^b   Ferret, Pierre Jacques ^c   Hammoud, Renaud ^a,b   Tulliez, Micheline ^b   Bedda, Sassia ^a   Trébéden, Hélène ^c   Jaffray, Patrick ^d   Calmus, Yvon ^e   Weill, Bernard ^a   Batteux, Frédéric ^a  

^a Laboratoire d'Immunologie   (France)

^b Service d'Hématologie   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSERM   (France)

^e Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BENZOIC ACID DERIVATIVE; CARDIOLIPIN; CASPASE 3; CYTOCHROME C; FAS ANTIBODY; FAS ANTIGEN; MANGANESE DERIVATIVE; MANGANESE TETRAKIS(5,10,15,20 BENZOIC ACID); MONOCLONAL ANTIBODY; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL DAMAGE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; LIVER CELL; LIVER FAILURE; LIVER PARENCHYMA; MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SURVIVAL; T LYMPHOCYTE; VIRUS HEPATITIS;

EID: 0035210750     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.29590     Document Type: Article

References (27)

1. Acute liver failure
2. Contribution of Fas ligand to T cell-mediated hepatic injury in mice
3. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
4. Essential roles of the Fas ligand in the development of hepatitis
5. Lethal effect of the anti-Fas antibody
6. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis
7. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha
8. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation
9. Dual signal of the Fas receptor: Initiation of both apoptotic and necrotic cell death pathways
10. Two CD95 (APO-1/Fas) signaling pathways
11. Apoptosis signaling in lymphocytes
12. The mitochondrial permeability transition augments Fas-in-duced apoptosis in mouse hepatocytes
13. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
14. Metalloporphyrin class of therapeutic catalytic antioxidants
15. Annexin 1 expression and phosphorylation are up-regulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice
16. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo
17. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
18. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis
19. Reactive oxygen species and programmed cell death
20. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
21. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice
22. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes
23. The Fas/Fas ligand pathway and Bcl-2 regulate T-cell responses to model self and foreign antigens
24. In vivo evidence that caspase-3 is required for Fasmediated apoptosis of hepatocytes
25. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL
26. Scientific basis for the clinical use of superoxide dismutase
27. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats